MY-012

N/A

Report date: 2023/06/26 09:16:06
NME

Base Information

Drug NameMY-012
Drug Alias NameMY-012
ClassificationSmall molecules
Mechanisms of ActionApoptosis-associated speck-like protein containing a CARD inhibitors
TargetsApoptosis-associated speck-like protein containing a CARD
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWuhan Createrna Science and Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Createrna Science and Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A